Kei Ohnuma

Summary

Affiliation: University of Tokyo
Country: Japan

Publications

  1. ncbi Cord blood transplantation from HLA-mismatched unrelated donors as a treatment for children with haematological malignancies
    K Ohnuma
    Division of Clinical Immunology, Advanced Clinical Research Centre, Institute of Medical Science, University of Tokyo, 4 6 1, Shirokanedai, Minato ku, Topkyo 108 8639, Japan
    Br J Haematol 112:981-7. 2001
  2. ncbi Cord blood transplantation from HLA-mismatched unrelated donors
    Kei Ohnuma
    Division of Clinical Immunology, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Japan
    Leuk Lymphoma 43:1029-34. 2002
  3. ncbi Localization of CD26/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effect
    Kohji Yamada
    Department of Pathology, Keio University School of Medicine, Tokyo, Japan
    Cancer Cell Int 9:17. 2009
  4. ncbi Mechanisms of confluence-dependent expression of CD26 in colon cancer cell lines
    Masako Abe
    Department of Hematologic Malignancies, Nevada Cancer Institute, Las Vegas, Nevada, 89135, USA
    BMC Cancer 11:51. 2011

Collaborators

  • K Isoyama
  • Masako Abe
  • Chikao Morimoto
  • Kohji Yamada
  • Nam H Dang
  • Pamela A Havre
  • Long H Dang
  • Yasuyo Urasaki
  • Mutsumi Hayashi
  • Taketo Yamada
  • Wenlin Du
  • Michiie Sakamoto

Detail Information

Publications4

  1. ncbi Cord blood transplantation from HLA-mismatched unrelated donors as a treatment for children with haematological malignancies
    K Ohnuma
    Division of Clinical Immunology, Advanced Clinical Research Centre, Institute of Medical Science, University of Tokyo, 4 6 1, Shirokanedai, Minato ku, Topkyo 108 8639, Japan
    Br J Haematol 112:981-7. 2001
    ..013, RR 4.746, 95% CI 1.382-16.298). These data confirm that HLA-mismatched, unrelated CBT is a feasible procedure to cure a significant proportion of children with leukaemia, especially if conducted in a favourable phase of the disease...
  2. ncbi Cord blood transplantation from HLA-mismatched unrelated donors
    Kei Ohnuma
    Division of Clinical Immunology, Advanced Clinical Research Center, Institute of Medical Science, University of Tokyo, Japan
    Leuk Lymphoma 43:1029-34. 2002
    ..On the other hand, for engraftment, the use of UCBT from HLA-mismatched unrelated donors may require a larger study in patients with non-malignant diseases...
  3. ncbi Localization of CD26/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effect
    Kohji Yamada
    Department of Pathology, Keio University School of Medicine, Tokyo, Japan
    Cancer Cell Int 9:17. 2009
    ..CONCLUSION: These results indicate that the intra-nuclear CD26 which moves from plasma membrane may play certain roles in cell growth of human cancer cells...
  4. ncbi Mechanisms of confluence-dependent expression of CD26 in colon cancer cell lines
    Masako Abe
    Department of Hematologic Malignancies, Nevada Cancer Institute, Las Vegas, Nevada, 89135, USA
    BMC Cancer 11:51. 2011
    ..Our work evaluates the mechanism involved in confluence-dependent CD26 expression in colon cancer...